Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes-Reference-Cited by-同舟云学术

Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes

Published:2019-10 Issue:10 Volume:14 Page:1784-1793
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Offin Michael^ORCID,Chan Joseph M.,Tenet Megan,Rizvi Hira A.,Shen Ronglai,Riely Gregory J.,Rekhtman Natasha,Daneshbod Yahya,Quintanal-Villalonga Alvaro,Penson Alexander,Hellmann Matthew D.,Arcila Maria E.,Ladanyi Marc,Pe’er Dana,Kris Mark G.,Rudin Charles M.,Yu Helena A.

Funder

Foundation for the National Institutes of Health

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies;Jordan;Cancer Discov,2017

2. Osimertinib in untreated EGFR-mutated advanced non–small-cell lung cancer;Soria;N Engl J Med,2018

3. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers;Yu;Clin Cancer Res,2013

4. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors;Sequist;Sci Transl Med,2011

5. Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion;Piotrowska;Cancer Discov,2018

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer;Translational Oncology;2024-11

2. Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma;JTO Clinical and Research Reports;2024-09

3. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

4. Mechanism of Fuzheng Qudu prescription in the treatment of lung cancer based on network pharmacology and experimental validation;Heliyon;2024-09

5. Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement;Journal of Translational Medicine;2024-08-31